Courtesy of News1임여익 기자 Qurient Expands Dual Payload ADC Technology: What This Means for Cancer Treatment in 2026SOT106: The Breakthrough ADC for Osteosarcoma and Soft Tissue Sarcoma Secures FDA Fast Track Status
